Form 4: Orchestra BioMed CFO's Routine Stock Withholding for Taxes

Orchestra BioMed CFO Andrew Taylor reported the withholding of 3,071 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on November 25, 2025.
• The transaction involved the disposition of 3,071 shares of common stock, valued at $5.35 per share, for tax withholding purposes.
• This disposition was solely to satisfy tax obligations in connection with the vesting of restricted stock units.
• No shares were sold in the open market as a result of this vesting and tax satisfaction.
• Following this transaction, Mr. Taylor beneficially owns 463,615 shares of Orchestra BioMed Holdings, Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction where shares were withheld to cover tax obligations related to restricted stock unit vesting. This is a standard administrative event and does not reflect a discretionary sale or purchase, thus having a neutral impact on sentiment.

Positives

• No shares were sold in the open market by the CFO, indicating the transaction was solely for tax compliance rather than a discretionary sale.

Future Outlook

NA

Management Comments

• Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.
• No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax compliance, which is common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends for the biotechnology or medical device sectors.

Comparison to Industry Standards

• The withholding of shares to cover tax obligations upon the vesting of restricted stock units is a standard practice for executive compensation in publicly traded companies across various industries.
• This mechanism is widely used to manage tax liabilities without requiring the executive to sell shares in the open market, which can be viewed positively by investors as it avoids signaling a lack of confidence.

Stakeholder Impact

• Shareholders: Minimal direct impact as it is a routine tax-related transaction and no shares were sold in the open market.
• Employees: No direct impact beyond the reporting person.

Key Dates

Keywords

Orchestra BioMed Holdings, OBIO, Andrew Taylor, CFO, Form 4, Insider Transaction, Stock Withholding, Restricted Stock Units, Tax Obligations